Profile data is unavailable for this security.
About the company
Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.
- Revenue in EUR (TTM)0.00
- Net income in EUR-22.06m
- Incorporated2009
- Employees50.00
- LocationSensorion SA375, rue du Professeur Joseph BlayacMONTPELLIER 34080FranceFRA
- Phone+33 467207730
- Fax+33 499545884
- Websitehttps://www.sensorion-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novacyt SA | 13.78m | -33.09m | 60.27m | 270.00 | -- | 0.58 | -- | 4.37 | -0.4685 | -0.4768 | 0.1951 | 1.47 | 0.0843 | 2.60 | 0.4406 | 51,042.48 | -20.24 | 10.94 | -25.17 | 14.49 | 32.21 | 61.98 | -240.09 | 17.64 | 2.82 | -- | 0.1419 | -- | -44.97 | -0.9408 | -25.22 | -- | 2.09 | -- |
| Adocia SA | 2.15m | -21.16m | 82.74m | 78.00 | -- | -- | -- | 38.48 | -1.93 | -1.93 | 0.194 | -0.4908 | 0.0774 | 2.62 | 7.44 | 27,564.10 | -76.16 | -43.08 | -396.14 | -72.93 | 7.91 | -- | -984.28 | -514.53 | 1.01 | -2.07 | 2.12 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Inventiva SA | 17.48m | -110.43m | 98.66m | 112.00 | -- | -- | -- | 5.64 | -2.45 | -2.45 | 0.3854 | -0.6146 | 0.1884 | -- | 9.18 | 156,044.60 | -116.84 | -54.30 | -207.08 | -69.98 | -- | -- | -620.31 | -669.97 | 0.9524 | -19.98 | 6.96 | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
| Maat Pharma SA | 2.23m | -19.72m | 101.60m | 50.00 | -- | 4.14 | -- | 45.60 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Eurofins-Cerep SA | 44.07m | 7.64m | 107.94m | 228.00 | 14.13 | 1.67 | 11.23 | 2.45 | 1,514.43 | 1,514.43 | 8,743.94 | 12,820.37 | 0.5864 | 1.67 | 5.08 | 193,287.10 | 10.16 | 14.21 | 12.22 | 17.51 | 85.01 | 73.61 | 17.33 | 19.77 | 4.87 | -- | 0.00005 | -- | -7.47 | 11.60 | -33.72 | 14.64 | -- | -- |
| Transgene SA | 7.63m | -22.33m | 135.20m | 158.00 | -- | 6.58 | -- | 17.71 | -0.2227 | -0.2227 | 0.0759 | 0.1553 | 0.1368 | -- | 4.28 | 48,316.46 | -40.00 | -24.81 | -50.27 | -29.79 | -- | -- | -292.48 | -193.24 | -- | -- | 0.4764 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
| Cellectis SA | 17.59m | -88.47m | 149.23m | 235.00 | -- | 1.12 | -- | 8.48 | -1.39 | -1.11 | 0.2345 | 1.86 | 0.0619 | -- | 3.86 | 74,861.99 | -31.74 | -24.08 | -46.51 | -30.69 | -- | -64.64 | -513.02 | -308.24 | -- | -6.95 | 0.4142 | -- | -64.26 | -15.57 | -20.55 | -- | -26.15 | -- |
| Innate Pharma SA | 24.85m | -34.05m | 165.98m | 168.00 | -- | 5.76 | -- | 6.68 | -0.4215 | -0.4215 | 0.3078 | 0.3557 | 0.1418 | -- | 14.93 | 138,826.80 | -19.43 | -8.83 | -24.80 | -12.11 | 88.00 | 93.17 | -137.03 | -55.55 | -- | -- | 0.7527 | -- | 4.68 | -8.27 | 86.94 | -- | 10.50 | -- |
| Ose Immunotherapeutics SA | 2.23m | -23.00m | 167.34m | 55.00 | -- | 7.21 | -- | 75.14 | -1.18 | -1.18 | 0.1138 | 1.06 | 0.0256 | -- | 3.22 | 40,490.91 | -26.46 | -17.17 | -33.15 | -20.55 | -- | -- | -1,032.87 | -94.71 | -- | -55.59 | 0.6659 | -- | -87.83 | -38.07 | -29.52 | -- | -17.11 | -- |
| Genfit SA | 38.18m | -28.89m | 195.26m | 159.00 | -- | 2.87 | -- | 5.11 | -0.5814 | -0.5814 | 0.7681 | 1.36 | 0.1961 | 542.00 | 3.52 | 240,100.60 | -14.84 | -12.57 | -18.55 | -15.30 | 94.32 | 94.96 | -75.69 | -76.23 | 2.94 | -7.78 | 0.5080 | -- | 43.70 | 38.49 | -21.82 | -- | -3.27 | -- |
| Nanobiotix SA | 36.22m | -33.47m | 218.98m | 102.00 | -- | -- | -- | 6.05 | -0.763 | -0.763 | 0.8429 | -0.4594 | 0.57 | -- | 17.20 | 355,107.80 | -52.68 | -54.11 | -323.15 | -80.68 | -- | -- | -92.42 | -756.15 | -- | -2.42 | 1.87 | -- | -- | 203.88 | 30.40 | -- | -7.81 | -- |
| Eurobio Scientific SA | 130.00m | 4.84m | 255.71m | 137.00 | 57.83 | 1.56 | 14.22 | 1.97 | 0.4315 | 0.4315 | 11.59 | 16.02 | 0.4018 | 3.19 | 4.31 | 948,927.00 | 1.49 | 16.91 | 1.80 | 21.53 | 47.11 | 50.95 | 3.72 | 23.34 | 2.32 | 4.03 | 0.3666 | 0.00 | -14.81 | 20.80 | -80.61 | -- | 20.02 | -- |
| Sensorion SA | 0.00 | -22.06m | 272.86m | 50.00 | -- | 5.10 | -- | -- | -0.2063 | -0.2063 | 0.00 | 0.1779 | 0.00 | -- | -- | -- | -51.64 | -35.12 | -71.66 | -46.97 | -- | -- | -- | -- | -- | -- | 0.0794 | -- | -- | -- | 4.94 | -- | 126.45 | -- |
Data as of Sep 20 2024. Currency figures normalised to Sensorion SA's reporting currency: Euro EUR
54.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invus Public Equities Advisors LLCas of 31 Dec 2023 | 78.35m | 26.07% |
| Redmile Group LLCas of 31 Dec 2023 | 63.27m | 21.06% |
| Fidelity Management & Research Co. LLCas of 31 Jul 2024 | 20.28m | 6.75% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2024 | 540.49k | 0.18% |
| Equitable Investment Management Group LLCas of 30 Jun 2024 | 125.89k | 0.04% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
